Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024
Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on dermatological products, has announced it will report its financial results for Q2 2024 on August 14, 2024, after market close. The company will host a conference call and webcast to discuss these results on August 15, 2024, at 10:00 AM ET.
Investors and interested parties can access the conference call by dialing 1-877-877-1275 (U.S.) or 1-412-858-5202 (international). A webcast of the call will also be available at the provided link. This announcement indicates Biofrontera's commitment to transparency and shareholder communication, allowing stakeholders to gain insights into the company's financial performance and business updates for the second quarter of 2024.
Biofrontera Inc. (Nasdaq: BFRI), un'azienda biofarmaceutica specializzata in prodotti dermatologici, ha annunciato che comunicherà i suoi risultati finanziari per il secondo trimestre del 2024 il 14 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast per discutere di questi risultati il 15 agosto 2024, alle 10:00 ET.
Investitori e parti interessate possono partecipare alla conferenza telefonica componendo il numero 1-877-877-1275 (USA) o 1-412-858-5202 (internazionale). Un webcast della chiamata sarà inoltre disponibile al link fornito. Questo annuncio evidenzia l'impegno di Biofrontera per la trasparenza e la comunicazione con gli azionisti, consentendo agli stakeholder di ottenere approfondimenti sulle performance finanziarie e gli aggiornamenti aziendali del secondo trimestre del 2024.
Biofrontera Inc. (Nasdaq: BFRI), una compañía biofarmacéutica enfocada en productos dermatológicos, ha anunciado que reportará sus resultados financieros del segundo trimestre de 2024 el 14 de agosto de 2024, después del cierre del mercado. La compañía organizará una conferencia telefónica y un webcast para discutir estos resultados el 15 de agosto de 2024, a las 10:00 AM ET.
Los inversores y partes interesadas pueden acceder a la conferencia telefónica marcando el 1-877-877-1275 (EE.UU.) o el 1-412-858-5202 (internacional). También estará disponible un webcast de la llamada en el enlace proporcionado. Este anuncio indica el compromiso de Biofrontera con la transparencia y la comunicación con los accionistas, permitiendo a los interesados obtener información sobre el rendimiento financiero y las actualizaciones comerciales del segundo trimestre de 2024.
Biofrontera Inc. (Nasdaq: BFRI)는 피부과 제품에 집중하는 생명공학 회사로, 2024년 2분기 재무 결과를 2024년 8월 14일에 시장 종료 후 발표할 것이라고 발표했습니다. 이 회사는 이러한 결과에 대해 논의하기 위해 2024년 8월 15일 오후 10:00 ET에 전화 회의와 웹캐스트를 개최할 예정입니다.
투자자와 이해관계자는 1-877-877-1275 (미국) 또는 1-412-858-5202 (국제)로 전화를 걸어 회의에 참여할 수 있습니다. 또한 제공된 링크에서 회의의 웹캐스트도 이용할 수 있습니다. 이 발표는 Biofrontera의 투명성과 주주 커뮤니케이션에 대한 헌신을 나타내며, 이해관계자들이 2024년 2분기의 재무 성과와 비즈니스 업데이트에 대해 통찰력을 얻을 수 있도록 합니다.
Biofrontera Inc. (Nasdaq: BFRI), une entreprise biopharmaceutique spécialisée dans les produits dermatologiques, a annoncé qu'elle publiera ses résultats financiers pour le deuxième trimestre 2024 le 14 août 2024, après la clôture du marché. L'entreprise organisera une conférence téléphonique et un webinaire pour discuter de ces résultats le 15 août 2024 à 10h00 ET.
Les investisseurs et les parties intéressées peuvent accéder à la conférence téléphonique en composant le 1-877-877-1275 (États-Unis) ou le 1-412-858-5202 (international). Un webinaire de l'appel sera également disponible via le lien fourni. Cette annonce témoigne de l'engagement de Biofrontera envers la transparence et la communication avec ses actionnaires, permettant ainsi aux parties prenantes d'obtenir des informations sur la performance financière et les mises à jour commerciales pour le deuxième trimestre 2024.
Biofrontera Inc. (Nasdaq: BFRI), ein biopharmazeutisches Unternehmen, das sich auf dermatologische Produkte spezialisiert hat, hat bekannt gegeben, dass es seine finanziellen Ergebnisse für das zweite Quartal 2024 am 14. August 2024, nach Börsenschluss, veröffentlichen wird. Das Unternehmen wird am 15. August 2024 um 10:00 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um diese Ergebnisse zu besprechen.
Investoren und interessierte Parteien können an der Telefonkonferenz teilnehmen, indem sie 1-877-877-1275 (USA) oder 1-412-858-5202 (international) anrufen. Ein Webcast der Konferenz wird ebenfalls über den bereitgestellten Link verfügbar sein. Diese Ankündigung zeigt Biofronteras Engagement für Transparenz und Kommunikation mit den Aktionären, was den Interessengruppen ermöglicht, Einblicke in die finanzielle Leistung und Geschäftsaktualisierungen für das zweite Quartal 2024 zu gewinnen.
- Timely reporting of quarterly financial results
- Providing multiple access options for investors (conference call and webcast)
- None.
WOBURN, MA / ACCESSWIRE / August 9, 2024 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2024 on Wednesday, August 14, 2024. The results will be released after the market close on Wednesday, Aug 14 and the company will host a conference call on Thursday, August 15 at 10:00am Eastern Time.
Conference Call and Webcast Information
Event | Biofrontera Inc. Second Quarter 2024 Financial Results and Business Update Conference Call |
Date | Thursday, August 15, 2024 |
Time | 10:00am ET |
Conference Call | 1-877-877-1275 (U.S.) 1-412-858-5202 (international) |
Webcast | https://event.choruscall.com/mediaframe/webcast.html?webcastid=bU2HFqrt |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.
Contacts:
Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com
SOURCE: Biofrontera Inc.
View the original press release on accesswire.com
FAQ
When will Biofrontera Inc. (BFRI) report its Q2 2024 financial results?
What is the date and time of Biofrontera's (BFRI) Q2 2024 earnings conference call?
How can investors access Biofrontera's (BFRI) Q2 2024 earnings call?
What period will Biofrontera's (BFRI) upcoming financial results cover?
